Skip to main content

Table 2 Angiogenic and inflammation markers of subjects at the time of the trial

From: Stable phase post-MI patients have elevated VEGF levels correlated with inflammation markers, but not with atherosclerotic burden

Parameter

Controls (N = 25)

Patients (N = 41)

p

VEGF (pg/ml)

36.3. ±8.9

53.8 ± 42.7

0.014

Angiogenin (pg/ml)

1.42 ± 0.38

1.37 ± 0.46

0.318

hs CRP (mg/l)

1.5 +/- 1.4

3.5 +/- 8.1

0.038

IL-6 (ng/ml)

2.5 ± 3.4

4.9 ± 4.1

0.016

IL-8

5.4 +/- 1.3

6.3+/- 3.0

0.102

IL-8 (pg/ml)

5.4 ± 1.3

6.3 ± 3.0

0.102

hs CRP (mg/ml)

1.5 ± 1.4

3.5 ± 8.1

0.038

VCAM-1 (ng/ml)

286.5 ± 60.1

283.3 ± 52.1

0.336

ICAM-1 (ng/ml)

182.3 ± 50.3

190.9 ± 44.9

0.775

Selectin-P (ng/ml)

52.9 ± 10.9

55.1 ± 13.4

0.373

Selectin-E (ng/ml)

44.7 ± 12.5

47.4 ± 14.8

0.112

TNF-α (ng/ml)

1.19 ± 1.12

0.93 ± 1.0

0.780

  1. Values are shown as means and standard deviations; VEGF-vascular endothelial growth factor, IL-6 – interleukin 6, IL-8 – interleukin 8, hsCRP – high sensitive C-reactive protein, VCAM-1 – vascular cell adhesion molecule-1, ICAM-1 – intracellular adhesion molecule-1, TNF-α – tumour necrosis factor α.